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PEl\lBANGUNAN UJIAN REAKSI BERANTAI 
POLIMERASI BERGANDA STABIL SUHU UNTUK 
PENGESA.NAN PANT AS STAPHYLOL"OCCUS 
AUREUS YANG RINTANG METHICILLIN 
Abstrak 
Staphylococcus aureus rintang methicillin (MRSA) bertanggungjawab terhadap 
kebanyakan jangkitan nosokomial dan komuniti. Ujian kultur konvensional 
mengambil masa selama dua hingga lima hari untuk menghasilkan maklumat penuh 
mengenai organisma dan pola kerintangan antibiotiknya. Oleh itu, kajian ini bertujuan 
untuk membangunkan ujian reaksi berantai polimerasi berganda untuk pengesanan 
MRSA dengan pantas. Ujian ini akan mengesan lima gen iaitu 16S rRNA gen dari 
genus Staphylococcus,femA Staphylococcus aureus, mecA yang mengekod rintangan 
methicillin, lukS yang mengekod pengeluaran leukosidin Panton-Valentine (PVL), 
sitotoksin nekrosis, dan satu gen kawalan dalaman secara serentak. Pasangan primer 
yang unik dan khusus telah pireka untuk mengamplifikasi lima gen dengan produk 
reaksi . berantai polimerasi pada julat 151 hingga 7 59 bp. Primer yang spesifik 
disahkan berdasarkan urutan jujukan DNA produk reaksi berantai polimerasi berganda 
dan analisa Blast. Kepekaan dan kekhususan ujian polimerasi berganda ini telah 
dibandingkan dengan kaedah kultur konvensional. Reaksi berantai polimerasi 
berganda ini dijadikan stabil- suhu dan ujian pantas kestabilan telah dinilai pada suhu 
bilik, 37°C dan 1 ooc. Ujian kepekaan analitikal pada peringkat DNA didapati adalah 
10 ng. 
XVll 
Analisa 34 strain rujukan Staphylococcus dan strain bukan Staphylococcus terhadap 
ujian menunjukkan keputusan 100% spesifik. Campuran reaksi berantai polimerasi 
berganda yang disimpan pada 1 0°C didapati stabil sehingga dua setengah tahun 
menurut ujian pantas kestabilan. Kejituan diagnostik ditentukan dengan menggunakan 
sejumlah 231 sampel swab nasal isolat klinikal. Daripada 231 swab tersebut, hanya 
207 menunjukkan pertumbuhan positif untuk Staphylococcus. Daripada 207 isolat 
Staphylococcus, 59 disahkan Staphylococcus aureus, manakala 148 adalah CoNS. 
Daripada 59 isolat Staphylococcus, 14 didapati rintang methicillin dan menunjukkan 
gen mecA. Kehadiran kawalan dalaman pada ujian reaksi berantai polimerasi berganda 
membantu dalam menyingkirkan kes negatif palsu. Reaksi berantai polimerasi 
berganda adalah tegap dan boleh memberi maklumat mengenai 5 gen yang amat 
penting untuk mengenalpasti spesis Staphylococcus dan pola rintangan methicillin 
mereka. Reaksi berantai polimerasi berganda yang dibangunkan dalam kajian ini 
boleh digunakan sebagai alat yang berkesan untuk penyaringan dan pengesanan 
pembawa MRSA di hospital dan di komuniti. 
XVlll 
DEVELOPMENT OF A THER.l\10STABILIZED 
MULTIPI_JEX PCR ASSAY FOR THE RAPID 
DETECTION OF l\1ETHICILLIN-RESISTANT 
STAPHYLOCOCCUS AUREUS 
ABSTRACT 
The emergence of methicillin-resistant Staphylococcus aureus (MRSA) is 
responsible for nosocomial and community-acquired infections. The conventional 
culture test takes 2-5 days to yield complete information of the organism and its 
antibiotic sensitivity pattern. Hence our present study was focused on developing a 
multiplex PCR assay for the rapid detection of MRSA. The assay simultaneously 
detected five genes, namely 16S rRNA of the Staphylococcus genus,femA of S. aureus, 
mecA that encodes methicillin resistance, lukS that encodes production of Panton-
Valentine leukocidin (PVL), a necrotizing cytotoxin and one internal control. Unique 
and specific primer pairs were designed to amplify the 5 genes with the PCR products 
ranging from 151 to 759 bp. The specificity of the primers was confirmed by DNA 
I 
sequencing of the multiplex PCR products and BLAST analysis. The sensitivity and 
specificity of multiplex PCR assay was evaluated against the conventional culture 
method. The multiplex PCR was thermostabilized and an accelerated stability test was 
evaluated at room temperature, 37°C and 10°C. The analytical sensitivity of the assay 
was found to be I 0 ng at the DNA level while the analytical specificity was evaluated 
with 34 reference staphylococci and non-staphylococcal strains and was found to be 
100%. The thermostabilized multiplex PCR mix stored at 1 0°C was stable up to two and 
a half years by the accelerated stability test. The diagnostic accuracy was determined 
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using a total of 231 nasal swabs clinical isolates. Among these 231 swabs, only 207 
showed positive growth for staphylococci. Of these 207, 59 \vere found to be S. aureus 
while 148 were coagulase-negative staphylococci. Out of the 59 S. aureus isolates, 14 
were found to be resistant to methicillin and expressed mecA gene. The presence of an 
internal control in the multiplex PCR assay helped to rule out false negative cases. The 
multiplex PCR assay is robust and can give information about the 5 genes that are 
essential for the identification of the Staphylococcus species and their methicillin 
resistance pattern. The PCR assay developed in this study can be used as an effective 
tool for screening and diagnosis ofMRSA nasal carrier in hospitals and community. 
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CHAPTER ONE: INTRODUCTION 
1.1 INTRODUCTION 
1.1.1 History and significance of Staphylococcus 
Genus Staphylococcus is one of the most common human pathogens and is capable of 
causing numerous and serious infections. Although primary S. aureus infections are 
not common, a great deal of the virulence from this organism occurs through cross-
infection by spread from patient to patient in hospitals and other institutional settings. 
In contrast, healthy individuals can be carriers of the organism (Maino us et al., 2006). 
Nosocomial infections cause a significant crisis for health and economics worldwide. 
A nosocomial infection is defined as an infection acquired in hospital, and which is 
not in the incubation phase on the patient's admission to hospital (Gamer eta!., 1988). 
Any microorganism including bacteria, parasites, fungi, or viruses can cause 
nosocomial infections, but bacteria are the most prevalent organisms. Staphylococci 
were among most common Gram-positive bacteria that causes nosocomial infections 
(Harbarth et al., 2008). S. aureus, in particular, is a lepding cause of diseases ranging 
from mild skin and soft tissue infections to life-threatening illnesses, such as deep 
postsurgical infections, septicemia, and toxic shock syndrome (Zhang et al., 2004). 
Risk factors that predispose colonization or infection with multi-resistant species 
including S.aureus are advanced age, severity of illness, inter-institutional transfer, 
prolonged hospital stay, gastrointestinal surgery, transplantation, exposure to medical 
devices and exposure to broad-spectrum antibiotics (Safdar and Maki, 2002). Strains 
of S. aureus resistant to all beta-lactam antibiotics, known as methicillin-resistant S. 
aureus (MRSA) causing considerable morbidity and mortality in hospitals. A low-
affinity penicillin-binding protein (PBPi or PBP2a) is produced by MRSA strains in 
addition to the normal PBPs. This altered PBP allows cell wall formation in the 
presence of antibiotic concentrations which inactivate other PBPs (Chapin and 
Musgnug, 2004). The gene encoding PBP2a has been named mecA and was found in 
all staphylococci sharing methicillin resistance mediated through PBP2a. The presence 
of mecA gene and expression of low-affinity PBP is considered the most important 
mechanism of methicillin resistance in S. aureus and other staphylococci (Barski et al., 
1996). In addition to all beta-lactam antibiotics MRSA is resistant also to, 
cephalosporins and staphylococcal penicillins (Berger-Bachi, 1999). The 
epidemiology of MRSA is changing constantly, the rates of methicillin resistance 
differ markedly among countries and range from< 1 percent in Scandinavia to >30 
percent in southern European countries (Prasad et al., 2000). 
1.1.1.1 Historical review of the emergence of Staphylococcus aureus and 
antimicrobial resistance 
The history of the emergence of resistance and changes in the epidemiology of 
infection with S. auerus is depicted in (Table 1.1 ). 
Table 1.1. Emergence of antimicrobial resistance and changing epidemiology of S. 
au reus 
,---· 
Events 
Aberdeen I 
Date 
1880 Sir Alexander Ogston discovered s. au reus In 
Scotland 
1928 Alexander Fleming discovered penicillin, usmg strains of 
Staphylococcus I 
1939 There were strains of Staphylococcus resistant to penicillin 
1940 Hospitals in the United Kingdom and the United States reported 
that 50% of S. aureus was resistant to penicillin 
1942 Penicillin used in humans 
1943 Beta-lactamase detected inS. aureus 
1950s Penicillin resistance common in hospital strains of S. aureus 
1957 Methicillin released in UK 
1961 MRSA reported in UK 
1960s Increasing reports of MRSA, multiple hospital outbreaks 
1966 First MRSA reported in Australia 
1970s Penicillin resistance common in community MSSA 
1976 Outbreaks of gentamycin resistant MRSA in Melbourne, UK 
Late 1970s Multiple MRSA outbreaks throughout world 
1981 Extensive outbreaks of Gentamycin resistance MRSA in Ireland, 
USA, Australia 
1980s MRSA becomes endemic in Australia, USA, other countries 
1990 MRSA endemic in most hospitals throughout the world 
1998 Emergence of strains of S. aureus resistance -to vancomycin, in 
L_:_ Japan, then USA 
I 
Note: Adapted and slightly modified from reference (Gosbell, 2003) appeared as table 
1.1 and page 2 in the source of original. 
1.2 CLASSIFICATION OF STAPHYLOCOCCUS SPECIES 
The main classification of staphylococcus is by presence or absence of coagulase 
production. Coagulase is a protein product, which is an enzyme that causes clot 
formation. 
1.2.1 Coagulase-positive Staphylococci 
The Coagulase-positive Staphylococcus included S. aureus and S. intermedius, S. 
delphini, S. lutrae and some strain of S. hyicus. Coagulase-positive pathogens have the 
ability to produce coagulase, a protein product which is an enzyme that causes clot 
formation while most other Staphylococcus species are coagulase-negative. However, 
the m·ajority of S. aureus are coagulase-positive, some may be atypical in that they do 
not produce coagulase. S. aureus is catalase positive which produce the enzyme 
catalase and able to convert hydrogen peroxide (H202) to water and oxygen, which 
makes the catalase test useful to distinguish Staphylococci from Enterococci and 
Streptococci. 
1.2.2 Coagulase-negative Staphylococci 
Coagulase-negative staphylococci (CoNS) are common colonizers of the human skin 
and the most frequent constituent of the normal flora at this site (Roth and James, 
1988). Once considered a relatively virulent and probably a contaminant when isolated 
from a clinical specimen, these organisms have become increasingly recognized as 
agents of clinically significant nosocomial bloodstream infections. There are 31 
species currently recognized in the genus staphylococcus, which are members of the 
Micrococcaceae family (Kloos and Bannerman, 1994 ). Although at least 18 species 
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have been isolated from human skin (Hamory eta/., 1987), S. epidermidis accounts for 
more than half of resident staphylococci (Leeming et ai., 1984) with extensive 
distribution over the body surface. In terms of clinical isolates, S. epidermidis is 
clearly predominant, comprising more than 75 percent of CoNS in clinical specimens 
(Pfaller and Herwaldt, 1988), this is perhaps due to its sheer numbers on the skin 
surface, although it may possess virulence determinants that other CoNS lack (Haveri 
et al., 2007). Other clinically significant species include S. saprophyticus that is part of 
the normal vaginal flora is predominantly implicated in genitourinary tract infections 
in young adult Women (Wallmark et al., 1978), whileS. hominis, S. haemolyticus, S. 
, warneri, and S. simulans have been more rarely isolated as pathogens (Pfaller and 
Herwaldt, 1988). S. lugdunensis has increasingly been recognized as a cause of 
invasive infections that include endocarditis, osteomyelitis, and sepsis (Ebright et al., 
2004). 
1.3 STAPHYLOCOCCUS AUREUS STRUCTURE, VIRULENCE 
FACTORS, AND PATHOGENESIS 
1.3.1 Cell wall 
The outermost layers of pathogens are important in the infection process (Anthony and 
Hill, 1988). Most S. aureus isolates are covered by a polysaccharide capsule. Based on 
capsular polysaccharides S. aureus can be classified into eleven different serotypes. 
Beneath the capsuleS. aureus harbors a typical Gram positive cell wall (Giesbrecht et 
al., 1998). The Gram positive cell wall has a thicker and highly cross linked 
peptidoglycan layer than Gram negative and it lacks the outer membrane (Beveridge, 
1999, van Wely et al., 2001) (Figure 1.1). 
The peptidoglycan consists of glycan strands of N-acetylglucosamine-N-
acetylmuramic acid (GlcNAc-MurNAc) disaccharides, cross linked by tetrapeptides 
consisting of L-alanine, D-glutamine, L-lysine, and D-alanine. In S. aureus. a 
pentaglysine inter-bridge links the tetrapeptide units of adjacent glycan strands. S. 
aureus produces four penicillin-binding proteins (PBPs), PBP1-4, involved in the cell 
wall peptidoglycan assembly (Labischinski, 1992). PBP2 is a bifunctional protein 
which, in addition to transpeptidase activity, also acts as transglycosylase (Goffin and 
Ghuysen, 1998). PBPs bind effectively to beta-lactam antibiotics, and in the presence 
~f these agents, the cell wall assembly is discontinued. 
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Figure 1.1. Composition of cell wall of Gram-positive and Gram negative bacteria. 
Note: Adapted from reference (Cedric Mims, 2004) appeared as table 1.1 and page 2 
in the source of original. 
1.3.2 Genome of S. aureus 
The genomic positions of various genetic markers of S.aureus have been localized by 
creating physical maps of the genome. The development of S. aureus chromosomal 
maps began through definition of three linkage groups consisting of nine auxotrophic 
markers and a novobiocin resistance marker on S. aureus NCTC 8325 (Pattee and1 
Neveln, '1975). By inclusion of a large number of additional markers, and the use of 
pulsed field gel electrophoresis (PFGE) and subsequent hybridization with available 
probes, the physical map of S. aureus NCTC 8325 continued to be more and more 
precise (landolo, 2000) (Figure 1.2). However, until data from genome sequencing 
became available, the mutual distances between genetic markers within each PFGE 
fragment will be unkiwwn. 
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Figure 1.2. S. aureus NCTC 8325 physical map. Adapted from (Saara, 2002). 
Smal restriction fragments A-P, their sizes in kilobase pairs, and examples of 
identified genetic markers. 
1.3.3 Virulence factors 
The pathogenicity associated with S. aureus can be attributed to a number of virulence 
factors, such as enterotoxins, cytolytic toxin, and cellular components like protein A. 
I 
According to their biological function, the virulence factors can be divided into three 
groups: those involved in adhesion, in host defense evasion, and in tissue penetration 
(Table 1.2). 
1.3.3.1 Enterotoxins 
Staphylococcal enterotoxins are heat stable exotoxins that cause diarrhea and vomiting 
in humans. Eight serological distinct enterotoxins (A-E and G-I) have been identified 
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(Wieneke et al., 1 993). These toxins are produced by 30% to 50% of S. aureus isolates. 
These toxins along with toxic shock syndrome toxin··1 (TSST -1 ), are superantigens 
having the ability to activate a strong overactive immune response. TSST -1 causes 
nearly all cases of menstruating associated TSS. TSST-1 is a superantigen stimulating 
T cell proliferation and the subsequent production of a large concentration of 
cytokines that are responsible for the symptoms (Ladhani et al., 1999). 
1.3.3.2 Cytolytic toxins 
S. aureus produces other extracellular proteins that affect red blood cells and 
leukocytes. There are four types of hemolysins: alpha, beta, gamma and delta, a-
Hemolysin is dermonecrotic and neurotoxic, lyses erythrocytes, can damage platelets, 
macrophag·es and causes sever tissue damage (Bhakdi and Tranum-Jensen, 1991 ). 0-
Hemolysin, acts on sphengomyelin in the plasma membrane of erythrocytes. o-
Hemolysin, although found in a higher percentage of S. aureus and CoNS, is 
considered less toxic to cell surface than other hemolysins (Dinges et al., 2000). y-
Hen)olysin is often only found associated with Panton-Valentine leucocidin (PVL). 
Staphylococcal leucocidin, PVL, is an exotoxin that is lethal to polymorphonuclear 
leukocytes. It has been implicated as contributing to the invasiveness of the organism 
by suppressing phagocytosis and has been associated with sever cutaneous infections 
and necrotizing pneumonia. Although produced by relatively few strains of S. aureus, 
it has been associated with some cases of community-acquired staphylococcal 
infections (Dinges et al., 2000). 
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1.3.3.3 Enzymes 
Several enzymes are produced by staphylococci like coagulase, protease, 
hyaluronidase and lipase. Coagulase is produced mainly by S. aureus, although the 
exact role of coagulase in pathogenicity remains uncertain, it is considered a virulence 
marker (Siboo et al., 2001). Many strains of S. aureus produce hyaluronidase. This 
enzyme hydrolyzes hyaluronic acid present in the intracellular ground substance that 
makes up connective tissues, permitting the easy spread of bacteria during infection. 
Lipase is produced by both coagulase positive and coagulase- negative staphylococci. 
Lipases acts on lipid present on the surface of the skin, particularly fats and oil 
secreted by sebaceous glands. Protease, lipase and hyaluronidase are capable of 
··destroying tissue and may facilitate the spread of infection to adjoining tissues. 
1.3.3.4 Protein A 
Protein A is one of several cellular components that have been identified in the cell 
wall of S. aureus. The most important role of protein A in infections caused by S. 
aureus IS its ability to bind th'e Fe portion of immunoglobulin G (IgG), which 
eventually block phagocytosis (Harrison, 2007). 
Genes for S. aureus virulence factors may reside m plasmids, bacteriophages, 
transposons, or pathogenicity islands of the chromosome. Recent sequencing of two S. 
aureus strains revealed three new classes of pathogenicity islands: TSST family 
islands, exotoxin islands, and enterotoxin islands. A considerable number of putative 
virulence genes were also identified (Kuroda et al., 200 I) 
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Table1.2. Stapylococcus aureus virulence factors. 
Virulcnre fartor Gene Regulation Proposed virulence Production phase 
system function 
i Enterotoxin A entA agr Host defence evasion All 
Enterotoxins B-E, G-J entB-E, entG-J agr Host defence evasion Post exponential 
Hemolysin hlg agr Tissue penetration Post exponential 
Panton-Valentine lukF-PV. lukS - PV n.d. Host defence evasion Post exponential 
leucocidin 
Coagulase co a agr, sae Attachment Exponential 
Serine protease spr agr, sar Host defence evasion Post exponential 
Hyaluronidase hysA, hal agr Tissue penetration Post exponential 
Lipase geh agr, sar Host defence evasion Post exponential 
Protein A spa agr, sarA, Host defence evasion, Exponential 
sarS, sae attachment 
Clumping factor elf A sar Attachment Exponential 
Leucocidin R lukF-R, lukS-R agr Host defence evasion n.d. 
Fibrinogen binding jbaA agr, sar Attachment Exponential 
protein A 
Toxic shock syndrome tst agr, sar Host defence evasion Post exponential 
toxin 
Note: Adapted and modified from (Projan, 1997), (table 3-1) (n.d, not determined or 
not reported in the literature). 
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1.3.4 Pathogenesis and immune response 
Staphylococcal pathogenesis results from vanous bacterial activities mediated by 
virulence factors, and from the immunological response by the host. It is corrm1only 
thought· that bacterial adherence to host tissue is a prerequisite for colonization and 
infection (Patti et al., 1994 ). Subsequent survival, growth, and establishment of 
infection depend on the ability of the bacterium to circumvent host defense. The 
primary host response is mediated by polymorphonuclear leucocytes (V erdrengh and 
Tarkowski, 1997), which are attracted by expression of adhesion molecules on 
endothelial cells. The cell wall components, peptidoglycan and teichoic acids, trigger 
signaling pathways leading to the release of cytokines (Ellingsen et al., 2002). 
Leucocytes and other host cellular factors can be destructed by locally acting bacterial 
toxins. Anti-inflammatory response is also achieved by the staphylococcal 
extracellular adherence protein, which inhibits the recruitment of host leucocytes by 
direct interaction with the host adhesive proteins ICAM-1, fibrinogen, and vitronectin 
(Chavakis et al., 2002). The robust local inflammatory response may lead to the 
formation of an abscess. Inside an abscess, the bacteria gradually fall into a state of 
nutritional stress as the density ofbacteria increases. At this point the autoinduction of 
~ecreted virulence factors could enable the bacteria to break out and spread to new 
locations (Novick et a!., 1995). 
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In toxin mediated diseases, superantigens bind non-specifically to the maJor 
histocompatibility complex II (MHC II) and crosslink it to the variable beta chain of 
T-lymphocyte. Since the normal route of internalization, processing, and antigen 
presentation is bypassed, this unspecific binding leads to massive expansion ofT-
lymphocytes and production of cytokines. Superantigens also induce endotoxin 
hypersensitivity and bind directly to endothelial surfaces, probably causing capillary 
leakage through endothelial cell death or intercellular gap formation. 
In invasive diseases, such as sepsis and endocarditis, staphylococci must 
interact with the endothelium. The bacteria can adhere to damaged areas of the 
endothelium, or directly to the endothelial cell via the adhesin-receptor mechanism or 
via bridging ligands (Joh et al., 1999). The bacteria may then be phagocytized into 
endothelial cells and/or reach the underlining tissue (Lowy, 1998). Both endothelial 
phagocytosis and tissue invasion elicit an inflammatory response leading to the release 
of IL -1, -6, -8, tumor necrosis factor (TNF), and subsequently gamma interferon. 
Leucocytes adhere to endothelial cells and increase vascular permeability. Although S. 
aureus is primarily an extracellular pathogen, it may sometimes survive inside non-
professional phagocytes, such as fibroblasts, renal cells, and osteoblasts. Intracellular 
survival may explain the persistent and recurrent nature of certain staphylococcal 
infections (Proctor et al., 1995). Intracellular staphylococci often appear as small 
colony variants which have mutations affecting electron transport, and show slowly 
growing, nonpigmented colonies with reduced production of virulence factors (von 
Eiff et a!., 1997). 
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1.3.4.1 Infections caused by staphylococcus 
Staphylococcus aureus causes a wide variety of diseases, from mild skin infections to 
severe life threatening systemic infections (Waldvogel, 2000). It is a common cause of 
skin and subcutaneus infections, including folliculitis, furunculosis, cellulitis, mastitis, 
and impetigo. Recurrent abscesses of the skin and the subcutaneous tissue may be 
difficult to treat. The preferable treatment for folliculitis and local abscesses is surgical 
drainage, whereas cellulitis is usually treated with antimicrobials. Impetigo can range 
from mild, recurrent infections to a more severe bullous form and to the potentially 
life-threatening scalded skin syndrome (Ladhani et al., 1999). S. aureus is also 
commonly associated with postoperative wound infections, catheter-related infections, 
toxic shock syndrome (TSS), and food poisoning. TSS and food poisoning are toxin-
mediated diseases. The common, self-limiting, food poisoning is caused by 
enterotoxins present in contaminated food, and is characterized by nausea, vomiting, 
headache, and sometimes diarrhea. The symptoms start four to five hours after 
consumption of contaminated food (Wieneke et al., 1993). TSS, caused by TSST -1, is 
a potentially fatal condition, most commonly associated with the use of highly 
absorbent tampons, but also known in non-invasive S. aureus infections in children. 
The symptoms include high fever, rash, desquamation of skin one to two weeks after 
onset, hypotension, and involvement of multiple organ systems (Dinges et a!., 2000). 
Serious S. aureus infections include osteomyelitis, pneumonia, sepsis, acute 
endocarditis, myocarditis, pericarditis, cerebritis, meningitis, scalded skin syndrome, 
and sterile site abscesses (Waldvogel, 2000). S. aureus pneumonia is rare in a 
community setting, but fairly common in a hospital setting, especially as a 
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consequence of influenza in elderly patients (Lowy, 1998). Acute osteomyelitis 
primarily affects long bones in children, whereas chronic (duration of infection >6 
months) osteomyelitis is more common in adults after bacteremia, or as a complication 
of penetrating wounds (Waldvogel and Papageorgiou, 1980). S. aureus sepsis most 
often originates in a local infection focus such as cellulitis, pneumonia, or a wound, or 
is related to an intravascular device. Complicated sepsis may hematogenously spread 
the infection to other organs, such as hemt, bone, and joint (Lyytikainen et al., 2002) 
1.3.4.2 Staphylococcal nasal carriage 
Humans are a natural reservoir of S. aureus and the primary ecological niches of S. 
aureus are the anterior nares, although other body sites such as the throat, perineum, 
groin, and skin may also be colonized. S. aureus nasal carriage has been identified as a 
major risk factor in the development of infections not only in the hospital setting (von 
Eiff et al., 2001), but in the community as well (Wertheim et al., 2005). Many 
underlying diseases or conditions such as insulin-dependent diabetes mellitus, 
continuous ambulatory peritoneal dialysis, intravenous drug abuse, human 
immun9deficiency virus (HIV) infection, and S. aureus skin infections and other skin 
diseases have been associated with a higher S. aureus nasal carriage and subsequent 
infection rate (Berman et al., 1987, Luzar et al., 1990, Nguyen et al., 1999, Williams 
et al., 1998). According to cross-sectional studies, a mean carriage rate of 37% was 
found when investigating the prevalence and incidence of S. aureus nasal carriage 
(Kluytmans et al., 1997). The S. aureus nasal carriage rate may also have changed 
over the years; previous studies have reported higher rates than those published 
recently (Kluytmans et al., 1997, We1theim et al., 2005). Nasal caniage patterns differ 
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between healthy persons, and persistent carnage has been reported in 10-35% of 
individuals, 20-75% carry S aureus intermittently, and 5-50% never carry S. aureus 
(Kluytmans et a!., 1997). 
The non-carrier state may be attributable to bacterial interference vvith each 
other: when the ecological niche is already occupied by other bacteria such as CoNS 
or Corynebacterium species, S. aureus does not seem to replace the resident bacterial 
population (Hu et al., 1995). Persistent carriage is more common in young children 
than in adults, and the carriage pattern has been reported to change in many persons 
between age 10-20 (Armstrong-Esther, 1976). In addition, a persistent carriage rate is 
higher in males than in females, and depends on hormonal status (Eriksen et al., 1995). 
Significantly higher numbers of S. aureus bacteria have been reported in the 
nostrils of persistent carriers than in those of intermittent carriers, which results in an 
increased risk of S. aureus infections; elderly healthy persistent carriers had higher 
amounts of S. aureus bacteria than did young carriers (Nouwen et al., 2004). Based on 
molecular studies, the exchange rate of S. aureus strains has been reported to be 
significantly higher in intermittent carriers than in persistent carriers (Vander{Bergh et 
a!., 1999). Cespedes and colleagues have developed a mathematical model for 
investigating the frequency of the simultaneous nasal carriage of multiple strains of S. 
aureus (Cespedes et al., 2005). According to that study, 6.6% of S. aureus-colonized 
individuals carry more than one strain. The presence of more than one strain of S. 
aureus at the same time increases the potential for the horizontal transfer of genes, 
including virulence determinants or antimicrobial-resistance genes. This may be a 
problem when a single antibiotic-susceptible isolate, rather than another, more 
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resistant strain from patients infected with S. aureus is only detected. The treatment 
may therefore be unsuitable. 
1.4 ANTIMICROBIAL RESISTANCE IN STAPHYLOCOCCUS 
AUREUS 
Staphylococci are intrinsically resistant to broad-spectrum antimicrobial agents and 
this limits the choice of drugs for treatment. The increased prevalence of 
staphylococcal pathogens in nosocomial infections worldwide has resulted m 
antimicrobials being used in greater frequency in hospitals 
1.4.1 Mechanisms of antimicrobial resistance 
1.4.1.1 Resistance to Beta-lactams 
S. aureus can be resistant to Beta-lactams via several mechanisms below: 
(i) Production of Beta-lactamase (Penicillinase) conferring resistance to 
Penicillin 
Beta-lactams are known to bind to cell wall enzymes known as PBPs, the cross-
linking or transpeptidation reactions take place on the external surface of the 
cytoplasmic membrane in a reaction catalysed by PBPs. Beta-lactamase The ~-lactam 
antibiotics, inhibit the transpeptidation domain of PBPs, thus interfering with the 
cross-linking reaction (Stapleton and Taylor, 2002). Without cross-linking of the 
peptidoglycan, the cell wall becomes mechanically weak, some of the cytoplasmic 
contents are released and the cell dies (Giesbrecht et al., 1998). There are four PBPs in 
S. aureus, PBP1, PBP2, PBP3, and PBP4, which are essential for cell growth, and 
have high affinity for most ~-lactams. 
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(ii) Production of an altered Penicillin-binding protein (PBP 2a) conferring 
resistance to methicillin 
The term "methicillin resistance" denotes resistance of S. aureus to all ~-lactam 
antibiotics (penicillin, monobacams and carbapenms) due to the presence of an altered 
PBP in the cell wall known as PBP 2a (Berger-Bachi, 1997). PBP 2a is a 76-kDa and 
is the product of the gene mecA. There is no mecA homolog in susceptible strains. 
Both susceptible and resistant strains of S. aureus produce four major PBPs, PBPs 1, 2, 
3, and 4 (Chambers, 1997). PBPs catalyze the transpeptidation reaction that cross-
links the peptidoglycan of the bacterial cell wall. ~-lactam antibiotics are substrate 
analogs that covalently bind to the PBP active-site serine. PBPs 1, 2, and 3, have high 
affinity for most ~-lactam antibiotics, are essential for cell growth and for the survival 
of susceptible strains, and binding of ~-lactams by these PBPs is lethal (Chambers and 
Sachdeva, 1990). mecA is highly conserved among staphylococcal species. In 
methicillin-resistant cells, PBP 2a, with its low affinity for binding ~-lactam 
antibiotics can substitute for the essential functions of high-affinity PBPs at 
concentrations of antibiotic that are otherwise lethal (Utsui andY okota, 1985). 
(iii) Point mutations in penicillin-binding protein 
S. aureus may have a raised methicillin MIC by another mechanism. Point mutations 
may occur in the penicillin-binding domains of PBPs 1, 2 and 4, with a resultant 
reduction in affinity for ~-lactams (Tomasz et al., 1989). Other study found alterations 
in PBPs 2 and 4 in resistant mutants passaged in medium containing ~-lactams 
(Berger-Bachi et al., 1986). These altered PBPs bind penicillin more slowly and 
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released penicillin more rapidly (Chambers et al., 1994). These binding alterations are 
due to point mutations affecting the penicillin-binding domains (Hackbarth et al., 
1995). Over expression of PBPs, especially PBP4 may also result in low-level 
resistance as more enzyme is unbound and available for cell wall synthesis. These 
strain have been referred to as MODSA (modified S. aureus) (Berger-Bachi, 1997), 
although some authors classify these strains as also having borderline resistance 
(Chambers, 1997). 
(iv) Production of a novel enzyme with a higher affinity to methicillin or 
overproduction of beta-lactamase 
Borderline oxacillin-resistant S. aureus (BORSA) strains exhibit MICs to oxacillin or 
methicillin just above the CLSI breakpoints (oxacillin MIC 4-8 mg/L) and do not 
possess the mecA determinant (Chambers, 1997). The mechanism of resistance in 
BORSA is either a higher affinity to methicillin or overproduction of B- lactamase 
(Massidda et al., 1992). 
In the case of BORSA strains possessing "methicillinase", production of this 
enzyme is inducible. During the investigation of BORSA strains VU94 and 822 two 
beta-lactamases were detected in the membranes, with molecular weights of 13 and 30 
kDa. Both beta-lactamases were detected in the MRSA strain studied, but the 
susceptible strains possessed only the first enzyme. The 30-kDa ~- lactamase proved 
to be a methicillinase, and it can be one of the main causes of the borderline phenotype 
of BORSA strains (Keseru et al., 2005). 
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BORSA strains with overproduction of~- lactamase are mecA negative, show high 
level of ~- lactamase activity against benzylpenic11lin as well as partial and slow 
~-
hydrolysis ofmethicillin, oxacillin and cephalosporins (Kernodle et al., 1989). 
L4.1.2 Resistance to non- Beta lactams 
Most antibiotic resistance in S. aureus is encoded by plasmids, transposons and 
insertion sequences, allowing rapid spread of resistance from strain to strain and also 
from CoNS to S. aureus, many antibiotic resistance gene are shared between S. aureus 
and CoNS (Paulsen, 1997). Staphylococcal cassette chromosome mec (SCCmec) can 
act as a trap for the integration of other, unrelated resistance determinants (Berger-
Bachi, 1997). IS431 mec, specially, may serve as a target of integration of other 
insertion sequences or plasmids flanked by similar insertion sequence elements, Tn 
554 can also integrate upstream of mecA due to the presence of transposons 
attachment sites there (Stewm1 et al., 1994). 
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1.5 LABORATORY DIAGNOSIS 
S.aureus is a Gram positive coccus; it appears as grape-like clusters when viewed 
through a microscope nonmotile, non-spore forming, and catalase positive aerobic or 
anaerobic showing hemolytic and large golden-yellow colonies. Colonies produced 
after 18 to 24 hours of incubation appear cream-colored. Staphylococci are common 
isolates in the clinical laboratory and are responsible for several suppurative types of 
infections. The laboratory diagnostics is based on culture and biochemical tests, 
typical morphology, positive coagulase reaction, fermentation of mannitol and 
trehalose, and production of heat stabile nuclease (thermonuclease) Tables 1.3 and 1.4. 
The ability of coagulase to clot plasma is the most widely used method for 
identification. A four-hour tube coagulase test with reconstituted plasma is definitive, 
and a slide test for bound coagulase is a means of rapid screening for species 
identification (Kloos, 1999). 
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species 
Characteristics Staphylococci Enterococci Streptococci Aerococci Alloiococci Planococci Stomatococci Macrococci Micrococci Rothia 
Strict aerobe - - - - + + - ± + -
Facultative anaerobe d + + + - - + ± - + 
--
Motility - d - - - + - - - -
-------
5% NaCl d + + + + + - + + -
I ..c:: 
- lo. 
·- <:'1 
-l ~ 1;\li 6.5% NaCl + + d L+ + + - + + ..c:: <:'1 
--~u 
0 <:'1 lo.z 12% NaCl d (±) i + ND + ± d 
'-' 
-
I - -
I 
Catalase + - - - ± + ± + + ± 
Benzidine test + - - - - + + + + + 
Anaerobic acid from d + + (+) ND - + - - r+--
glucose I 
Lysostaphine - + + + ND + + - +-y~ 
(200~-tg/mL) 
-----
El)thromycin (0.4 + + - ND NO ND ND + - j_ND 
-
11g/mL) 
-~--
Bacitracin (0.04-U- + + d - ND ND - --- ---+-----~-J =--
disk) I ----
Note: Adapted from reference (Murray, 2003) appeared as table : Staphylococcus, Micrococcus, and other catalase positive 
cocci that grow aerobically. +, 90% or more strains positive; ±, 90<Yo or more strains weakly positive; -, 90% or more strains 
negative; d, 11% to 89% of strains positive; (), delayed reaction; ND, not determined. 
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--- -r -----
species S.simula~ Test S. aureus S. epi1ermidis S. haemolyticus S. lugdunensis S. saprophyticus S. schleiferi 
--
Colony pigment + - d d d - -
Staphylocoagulase + - - - - - + 
--
Clumping factor + - - (+) - + -
--
Heat-stable nuclease + - - - - + -
Alkaline phosphatase + + - - - + (d) 
Pyrrolidonyl arylamidase - - + + - + + 
Ornithine decarboxylase - (d) - + - - -
Urease d + d + - I - T 
~- Galactosidase - - - - + (+) + 
Acetoin production + + + + + + d 
--
Novobiocin resistance s s s s R s s 
Polymyxin B resistance s R s S/R s s s 
0-Trehalose + - + + + d d-
-
--f--- --a 0-Mannitol + - d - d - + 0 --
..:::: D-Mannose + (+) - + - + d 
"''b 
-- ------
·--
D-Turanose + (d) (d) (d) + - -
(J ~ 
D-Xylose 
-< .::: - - - - - - -
.c 0-Cellubiose 0 - - - - - - -
I. 
~ Maltose + + + + + - (±) ~ 
'-' Sucrose + + + + + - + 
--
Note: Adapted from reference (Murray, 2003) appeared as table : Staphylococcus, Micrococcus, and other catalase positive 
cocci that grow aerobically. +, 90% or more strains positive; ±, 90% or more strains weakly positive; -, 90% or more 
strains negative; d, 1 1% to 89% of strains positive; (), delayed reaction; R, resistant; S, sensitive. 
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